Clinical Trials List
2019-12-01 - 2022-12-31
Phase II
Recruiting7
ICD-10C24.8
Malignant neoplasm of overlapping sites of biliary tract
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9156.8
Malignant neoplasm of other specified sites of gallbladder and extrahepatic bile ducts
-
-
Trial Applicant
National Health Research Institutes
-
Sponsor
-
-
Trial scale
Taiwan Multiple Center
-
Update
2026/05/15
Investigators and Locations
Co-Principal Investigator
- Yung-Yeh Su Division of General Internal Medicine
- Chia-Jui Yen Division of General Internal Medicine
- Chien-Jui Huang Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tsai-Sheng Yang Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
- Wen-Chi Chou Division of Hematology & Oncology
- Chia-Hsun Hsieh Division of Hematology & Oncology
- Hung-Chih Hsu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yee Chao Division of Hematology & Oncology
- San-Chi Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Che-Hung Lin Division of Hematology & Oncology
- Ming-Hung Tsai Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- Chang-Fang Chiu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Li-Tzong Chen Division of General Internal Medicine
- 姜乃榕 Division of General Internal Medicine
- Hui-Jen Tsai Division of General Internal Medicine
- Shang-Hung Chen Division of General Internal Medicine
- Nai-Jung Chiang Division of General Internal Medicine
- Kwang-Yu Chang Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- HSIANG YAO SHIH Digestive System Department
- Chung-Feng Huang Digestive System Department
- Tsung-Jang Yeh Division of Hematology & Oncology
- Wang Yao-Kuang Digestive System Department
- 梁博程 Digestive System Department
- 高育青 Division of Hematology & Oncology
- I-CHEN WU Digestive System Department
- Yi-Hsun Chen Digestive System Department
- Hui-Ching Wang Division of Hematology & Oncology
- 黃駿逸 Digestive System Department
- Wen-Hung Hsu Digestive System Department
- Shih-Chang Chuang Division of Gastroenterological Surgery
- Jeng-Shiun Du Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chiun Hsu Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- YU-YUN SHAO Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- 郭弘揚 Division of Hematology & Oncology
- SHIH-HUNG YANG Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- Hsiang-Fong Kao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
48 participants
-
Global
48 participants
